Same PBM Conduct Means Same Insulin Price Trial, FTC Says

Federal Trade Commission staffers want Caremark Rx, Express Scripts and OptumRx kept together in a single in-house case accusing the pharmacy benefit managers of artificially inflating insulin prices through unfair rebate...

Already a subscriber? Click here to view full article